Euro Court Slams UK Bank Over Drugs

27 January 1997

The European Court of Justice has ruled against action taken by the Bankof England for the UK Treasury in refusing to allow the transfer of Yugoslav funds to Centro-Com Srl of Italy, to pay for drugs and medical products exported from Italy to Montenegro.

In May 1992, the United Nations imposed sanctions on the former Yugoslavia (Serbia and Montenegro) under Resolution 757, but these excluded goods for medical purposes and foodstuffs. In June 1992, the Bank of England indicated that it would consider applications to debit Serbian and Montenegrin accounts "where payments were made for charitable or humanitarian purposes," ie for medical and similar exports, from the UK or another country.

Centro-Com exported 15 consignments of drug items and blood-testing equipment to wholesalers in Montenegro in October 1992-January 1993, after obtaining approval from Italy and the UN Sanctions Committee. But the Treasury changed its policy because of reports of abuse of authorization procedures, including misdescription of goods, and restricted payment authorization to ex-UK exports only.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight